Biospace news

Syndicate content
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 8 hours 48 min ago

Rapport Therapeutics Snags $100M for Precision Approach to Neurological Diseases

Mon, 07/03/2023 - 02:00
Rapport Therapeutics Snags $100M for Precision Approach to Neurological Diseases 3/7/2023

Moderna Eyes Accelerated Approval for mRNA Cancer Vaccine

Mon, 07/03/2023 - 02:00
Moderna Eyes Accelerated Approval for mRNA Cancer Vaccine 3/7/2023

Lilly-Backed Volastra Enters Clinic with Amgen’s KIF18A Inhibitor

Mon, 07/03/2023 - 02:00
Lilly-Backed Volastra Enters Clinic with Amgen’s KIF18A Inhibitor 3/7/2023

Merck Preps Potential First Oral PCSK9 Inhibitor for Phase III

Mon, 07/03/2023 - 02:00
Merck Preps Potential First Oral PCSK9 Inhibitor for Phase III 3/7/2023

Small Study of BridgeBio's Dwarfism Drug Indicates Advantage over BioMarin

Mon, 07/03/2023 - 02:00
Small Study of BridgeBio's Dwarfism Drug Indicates Advantage over BioMarin 3/7/2023

AI Therapeutics Posts First Clinical Data for New ALS Mechanism

Sun, 06/04/2023 - 02:00
AI Therapeutics Posts First Clinical Data for New ALS Mechanism 4/6/2023

Hedge Fund Wages Proxy Battle with Exelixis Over R&D

Sun, 06/04/2023 - 02:00
Hedge Fund Wages Proxy Battle with Exelixis Over R&D 4/6/2023

NLRB Rules Severance Agreements with Nondisclosure Clauses are Unlawful

Sun, 06/04/2023 - 02:00
NLRB Rules Severance Agreements with Nondisclosure Clauses are Unlawful 4/6/2023

Pfizer Publishes Phase III RSV Data Ahead of May Decision

Sun, 06/04/2023 - 02:00
Pfizer Publishes Phase III RSV Data Ahead of May Decision 4/6/2023

How the IRA Will Affect Drug Development

Sun, 06/04/2023 - 02:00
How the IRA Will Affect Drug Development 4/6/2023

FDA Sets July Decision Date for Full Approval of Leqembi

Sat, 06/03/2023 - 02:00
FDA Sets July Decision Date for Full Approval of Leqembi 3/6/2023

Voyager Rolls on as Novartis Selects Two of Three CNS Targets

Sat, 06/03/2023 - 02:00
Voyager Rolls on as Novartis Selects Two of Three CNS Targets 3/6/2023

Full Results from Esperion's Cholesterol Drug Fail to Impress Investors

Sat, 06/03/2023 - 02:00
Full Results from Esperion's Cholesterol Drug Fail to Impress Investors 3/6/2023

Incyte Abandons Phase III Trial for Myelofibrosis Treatment

Sat, 06/03/2023 - 02:00
Incyte Abandons Phase III Trial for Myelofibrosis Treatment 3/6/2023

How to Nail Virtual Interviews & Networking Events

Sat, 06/03/2023 - 02:00
How to Nail Virtual Interviews & Networking Events 3/6/2023

FDA Action Alert: Roche and Acadia

Sat, 06/03/2023 - 02:00
FDA Action Alert: Roche and Acadia 3/6/2023

AbbVie’s Rinvoq Maintains Durability in Phase II Lupus Study

Wed, 05/31/2023 - 02:00
AbbVie’s Rinvoq Maintains Durability in Phase II Lupus Study 5/31/2023

FDA Puts Clinical Hold on PepGen’s DM1 Early-Stage Trial

Wed, 05/31/2023 - 02:00
FDA Puts Clinical Hold on PepGen’s DM1 Early-Stage Trial 5/31/2023

Sanofi Rebounds in MS with Mid-Stage Data for Anti-CD40L Antibody

Wed, 05/31/2023 - 02:00
Sanofi Rebounds in MS with Mid-Stage Data for Anti-CD40L Antibody 5/31/2023

Glyscend’s First-in-Class Oral Diabetes Drug Shows Phase II Promise

Wed, 05/31/2023 - 02:00
Glyscend’s First-in-Class Oral Diabetes Drug Shows Phase II Promise 5/31/2023